• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Sumitomo, Otsuka’s Schizophrenia Candidate Fails Phase III Trials

cafead

Administrator
Staff member
  • cafead   Jul 31, 2023 at 10:02: PM
via Sumitomo Pharma and Otsuka Pharmaceutical announced Monday that two Phase III studies of ulotaront failed to meet primary endpoints for acutely psychotic adults living with schizophrenia.

article source